source
- Merck's ADC sac-TMT gets its first global Phase 3 win ahead of scheduleAn experimental antibody-drug conjugate from Merck and China-based Kelun-Biotech succeeded in a global Phase 3 study for the first time, giving Merck a key pipeline victory as it approaches the pat…Endpoints · 2mo ago↗ source
- STAT+: Supreme Court rejects challenge to Medicare drug price negotiationThe rejection may make the pharma firms remaining lawsuits more difficult.STAT · 2mo ago↗ source
- The Supreme Court won't take up drugmakers' IRA casesThe Supreme Court says it won’t wade into the pharma industry’s yearslong legal battle over Medicare drug price negotiations. The justices declined to review multiple cases brought by AstraZeneca,…Endpoints · 2mo ago